Summary
- Current Price
- As of today, STOK price is $32.23, down -1.47% on
- Current Price All-Time High
- STOK price is currently -54.97% below its historical high of $71.58 set on
- Market Cap
- STOK current market cap is $2B, up +190.10% over the past 365 days
- Revenue
- STOK current annual revenue is $184.42M, up +404.50% year-over-year
- Next Earnings
- The next earnings release for STOK is on
Profile
| Metric | Value |
|---|---|
| Full Name | Stoke Therapeutics, Inc. |
| Ticker | NASDAQ: STOK |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | stoketherapeutics.com |
| Employees | 128 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $32.23 | |
| Price, 1D Change | -1.47% | |
| $2B | ||
| - | ||
| - | ||
| 0.86 | ||
| $184.42M | ||
| Revenue, 1Y Change | +404.50% | |
| -$0.12 | ||
| EPS, 1Y Change | +92.94% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.12 | ||
| EPS Estimate | -$3.62 | N/A |
| EPS Est. Change | -3,016.42% | N/A |
| $184.42M | ||
| Revenue Estimate | $30.14M | N/A |
| Revenue Est. Change | -83.66% | N/A |
| Current Price | $32.23 | |
| Price Target | $44.00 | - |
| Price Tgt. Change | +36.52% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.02 | -$1.65 | +18.43% | |
| $0.13 | -$0.12 | -188.78% | |
| -$3.62 | N/A | -3,016.42% | |
| -$3.45 | N/A | -2,864.75% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $17.92M | $36.56M | +104.03% | |
| $188.80M | $184.42M | -2.32% | |
| $30.14M | N/A | -83.66% | |
| $47.86M | N/A | -74.05% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $32.23 | |
| $31.57 | ||
| $30.44 | ||
| $29.47 | ||
| $30.79 | ||
| $0.37 | ||
| 0.86 | ||
| $1.58 | ||
| 60.01 | ||
| 45.85% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $184.42M | ||
| -$0.12 | ||
| $180.24M | ||
| 97.73% | ||
| -$20.59M | ||
| -11.16% | ||
| -$6.89M | ||
| -3.73% | ||
| -$16.41M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.01 | ||
| 5.28 | ||
| 5.28 | ||
| - | ||
| 3 | ||
| 18.24 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 75.38 | ||
| 6.02 | ||
| -8.17 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $352.46M | ||
| $285.16M | ||
| $418.43M | ||
| $305.70M | ||
| $65.98M | ||
| $57.88M | ||
| $4.15M | ||
| $3.01M | ||
| $4.94M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $191.31M | ||
| $200.83M | ||
| $4.18M | ||
| $0.00 | ||
| $4.18M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $45.59M | ||
| -$186.81M | ||
| $97.39M | ||
| $670.00K | ||
| $44.92M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wedbush | → | |
| Guggenheim | → | |
| Chardan Capital | → | |
| Canaccord Genuity | → | |
| Goldman Sachs | ||
| BTIG | → | |
| Canaccord Genuity | → | |
| BTIG | → | |
| Wedbush | → | |
| Chardan Capital | → |
Analyst sentiment
Institutional ownership
No data
Screeners with STOK
FAQ
- What is the ticker symbol for Stoke Therapeutics, Inc.?
- The ticker symbol for Stoke Therapeutics, Inc. is NASDAQ:STOK
- Does Stoke Therapeutics, Inc. pay dividends?
- No, Stoke Therapeutics, Inc. does not pay dividends
- What sector is Stoke Therapeutics, Inc. in?
- Stoke Therapeutics, Inc. is in the Healthcare sector
- What industry is Stoke Therapeutics, Inc. in?
- Stoke Therapeutics, Inc. is in the Biotechnology industry
- What country is Stoke Therapeutics, Inc. based in?
- Stoke Therapeutics, Inc. is headquartered in United States
- When did Stoke Therapeutics, Inc. go public?
- Stoke Therapeutics, Inc. initial public offering (IPO) was on June 19, 2019
- Is Stoke Therapeutics, Inc. in the S&P 500?
- No, Stoke Therapeutics, Inc. is not included in the S&P 500 index
- Is Stoke Therapeutics, Inc. in the NASDAQ 100?
- No, Stoke Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Stoke Therapeutics, Inc. in the Dow Jones?
- No, Stoke Therapeutics, Inc. is not included in the Dow Jones index
- When was Stoke Therapeutics, Inc. last earnings report?
- Stoke Therapeutics, Inc.'s most recent earnings report was on August 3, 2026
- When does Stoke Therapeutics, Inc. report earnings?
- The next expected earnings date for Stoke Therapeutics, Inc. is November 3, 2026
Data Sources & References
- STOK Official Website www.stoketherapeutics.com
- STOK Profile on Yahoo Finance finance.yahoo.com/quote/STOK
- STOK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/stok